Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-22-023992
Filing Date
2022-11-09
Accepted
2022-11-09 17:21:55
Documents
11
Effectiveness Date
2022-11-09

Document Format Files

Seq Description Document Type Size
1 S-8 tern-s8-q322.htm S-8 197777
2 EX-5.1 tern-ex5_1.htm EX-5.1 18563
3 EX-23.1 tern-ex23_1.htm EX-23.1 5718
4 EX-99.1(A) tern-ex99_1a.htm EX-99.1(A) 249018
5 EX-99.1(B) tern-ex99_1b.htm EX-99.1(B) 183500
6 EX-99.1(C) tern-ex99_1c.htm EX-99.1(C) 150532
7 EX-FILING FEES tern-exfiling_fees.htm EX-FILING FEES 27925
8 GRAPHIC img60210087_0.jpg GRAPHIC 3219
9 GRAPHIC img60210087_1.jpg GRAPHIC 2924
10 GRAPHIC img60210087_2.jpg GRAPHIC 8657
11 GRAPHIC img60210087_3.jpg GRAPHIC 2924
  Complete submission text file 0000950170-22-023992.txt   859043
Mailing Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404
Business Address 1065 EAST HILLSDALE BLVD., SUITE 100 FOSTER CITY CA 94404 650-525-5535 EXT.101
Terns Pharmaceuticals, Inc. (Filer) CIK: 0001831363 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-268277 | Film No.: 221374016
SIC: 2834 Pharmaceutical Preparations